Defined Cell Culture Highlights:
Programmable Organoids, Cell Transplantation, & Culture Analytics
October 19-25, 2026
New research in iPSC disease modeling, retinal cell transplantation, organoid engineering, blood-brain barrier models, and quantitative imaging showed how cell composition, culture duration, transplantation preparation, and analytical methods can shape experimental outcomes. Across these studies, culture workflows influenced lineage potential, tissue maturity, metabolic state, cell survival, and the interpretation of three-dimensional models.
AML-iPSC clones preserve differences in hematopoietic potential
A Stem Cells and Development study published October 19 characterized 34 acute myeloid leukemia-derived iPSC lines from 11 patients.
The researchers classified the lines according to whether they retained the patient-specific genetic abnormalities associated with leukemia. Mutation-positive and mutation-negative lines showed comparable differentiation into nonhematopoietic lineages. However, mutation-positive lines had a selective impairment in hematopoietic differentiation based on phenotypic measurements and colony forming assays.
This difference persisted across four independent hematopoietic differentiation platforms, suggesting that it reflected stable clone-specific biology rather than an artifact of one protocol. The residual hematopoietic progenitors generated from mutation-positive lines retained leukemia-associated abnormalities, immature blast-like morphology, and increased serial replating capacity.
The results emphasize that successful reprogramming and pluripotency do not erase lineage-specific disease phenotypes. Disease modeling workflows need to characterize multiple clones, confirm the genetic status of each line, and distinguish protocol variability from intrinsic differences in differentiation potential.
Read the AML-iPSC study here.
Pre-attachment improves retinal ganglion cell transplantation
A Stem Cell Research & Therapy paper published October 21 (early access) examined whether culture preparation before transplantation could improve the integration of human stem cell-derived retinal ganglion cells.
The researchers used retinal organoid-derived cells and compared direct transplantation with a pre-attachment step that allowed donor cells to adhere before intravitreal delivery. Pre-attached cells showed improved survival and axon regeneration on the host retina, with some axons extending into the optic nerve.
Experiments involving different donor-cell combinations also indicated that non-retinal ganglion cell populations within the transplanted material supported survival and regeneration. Single-cell RNA sequencing showed increased maturation and expression of axon-guidance receptors after pre-attachment and transplantation. Delivering the chemoattractant netrin behind the eye further increased axon extension into the optic nerve head.
The study demonstrates that the state of cells immediately before delivery can affect transplantation outcomes. Attachment history, recovery conditions, cellular composition, and guidance signals may all need to be treated as controlled manufacturing variables rather than minor handling details.
Read this early access retinal ganglion cell study here. This version is subject to further edits until the final version is prepared, as of today's date.
Programmable cell removal improves organoid composition
A Cell Stem Cell study published online October 22 introduced a genetic circuit strategy for selectively removing unwanted cells from human pluripotent stem cell-derived tissues.
The researchers developed a modified inducible caspase-9 system with reduced background activity and combined it with logic-gated sensors that could distinguish specific cell states. In a multilineage liver organoid model, the circuits identified and eliminated developmentally stalled hepatocyte-like cells that lacked albumin expression. Their removal allowed more mature albumin-positive cells to become enriched within the tissue.
MicroRNA-based gating protected endothelial-like cells from unintended apoptosis. The researchers also applied the system to a human post-implantation embryo model, where selective cell removal improved formation of the pro-amniotic cavity.
Many differentiation strategies focus on adding signals that promote desired cell types. This study addresses a complementary problem of removing off-target populations that remain after differentiation. The approach does not replace media optimization, but it shows how cell state sensing and selective removal could improve the composition and consistency of complex stem cell-derived tissues.
Read the programmable apoptosis study here.
Culture duration changes the metabolic state of iPSC-derived blood-brain barrier cells
A Fluids and Barriers of the CNS study published October 24 investigated blood-brain barrier cells differentiated from 10 donor-specific human iPSC lines.
The researchers generated brain capillary endothelial-like cells from adults with or without ADHD and with different PARK2 copy number variants. They compared the cells at the end of differentiation on day 10 with cells maintained in culture until day 17.
At day 10, the cells showed high transendothelial electrical resistance and low sodium fluorescein permeability. After prolonged culture, fluorescein permeability remained low, but electrical barrier integrity declined. The cells also shifted from glycolytic ATP production toward greater reliance on mitochondrial oxidative phosphorylation, while total ATP production decreased.
These culture duration effects were broader than the metabolic differences associated with ADHD or PARK2 genotype. The findings show that assay timing can become a major source of variation in donor-specific iPSC studies. Comparing lines at different intervals after differentiation could create apparent biological differences that primarily reflect adaptation to continued culture.
Read this open access blood-brain barrier study here.
Automated volume analysis standardizes spheroid and organoid measurements
A Cytotechnology paper published October 25 introduced SpheroQuaNNt, a web-based application for automated segmentation and volume estimation from brightfield images of spheroids and organoids.
The U-Net model was trained and validated using 615 microscopy images representing diverse three-dimensional cultures. These included monoculture and multicellular spheroids generated from human and canine tumor cell lines, human embryonic kidney cells, immune cell co-cultures, and organoids derived from human melanoma samples.
The model achieved 98.56% validation accuracy and an average Dice score of 0.9478. Its volume estimates agreed closely with measurements made independently by two experts. The application also successfully segmented all spheroids in a 30-image comparison set, while an existing ImageJ workflow successfully processed only 20%.
The method estimates volume from two-dimensional images using a semi-ellipsoidal approximation, so highly irregular structures remain a limitation. Even with that constraint, automated analysis can reduce operator-dependent variability and make longitudinal measurements of organoid growth and treatment response more practical.
Read this open access study here.
The week’s takeaway
AML-derived iPSC clones showed that genetic differences can produce stable lineage-specific effects across multiple differentiation protocols. Retinal transplantation experiments demonstrated that pre-attachment and supporting cell populations influence survival and axon growth. Programmable apoptosis circuits removed developmentally stalled cells from complex tissues. Blood-brain barrier models underwent substantial metabolic and functional changes during one additional week in culture, while automated imaging reduced subjectivity in three-dimensional culture measurements.
Reproducibility depends on more than selecting a differentiation protocol. Clone identity, culture age, cellular composition, pre-transplant handling, and quantitative analysis all contribute to the final phenotype and must be controlled alongside media composition.
Whether you are developing a PSC, organoid, cell therapy, or disease modeling workflow, reducing variability starts with well-characterized media and supplements. Defined Bioscience provides animal-free solutions and custom media development. Explore our products or contact us to discuss your workflow.
